US Tech 100

19,169.60

-0.20%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NYSE
K V Pharma CL B (KVB)
K V Pharma CL B (KVB) News

KVB

K V Pharma CL B (KVB)

K V Pharma CL B

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:KVB

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
06/18/2012	8:04AM	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVB	K V Pharma CL B
06/18/2012	6:08AM	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVB	K V Pharma CL B
11/16/2011	7:15PM	Business Wire	Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
11/02/2011	8:40PM	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
10/31/2011	8:30PM	Business Wire	Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
10/28/2011	3:30PM	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
10/24/2011	12:52PM	Business Wire	The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
10/20/2011	7:47PM	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
06/13/2011	7:00AM	PR Newswire (US)	K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call	NYSE:KVB	K V Pharma CL B
04/01/2011	2:08PM	Dow Jones News	UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry	NYSE:KVB	K V Pharma CL B
04/01/2011	9:28AM	Dow Jones News	K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move	NYSE:KVB	K V Pharma CL B
03/31/2011	4:28PM	Dow Jones News	Religious Groups Urge Drug Makers To Ease Up On Price Hikes	NYSE:KVB	K V Pharma CL B
03/30/2011	2:58PM	Dow Jones News	UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVB	K V Pharma CL B
03/30/2011	11:38AM	Dow Jones News	K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVB	K V Pharma CL B
03/01/2011	7:49AM	PR Newswire (US)	K-V Pharmaceutical Company Announces $200 Million Private Debt Offering	NYSE:KVB	K V Pharma CL B
02/14/2011	9:34AM	PR Newswire (US)	K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue	NYSE:KVB	K V Pharma CL B
02/14/2011	8:48AM	PR Newswire (US)	K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock	NYSE:KVB	K V Pharma CL B
02/04/2011	7:40AM	PR Newswire (US)	K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011	NYSE:KVB	K V Pharma CL B
01/12/2011	8:03AM	PR Newswire (US)	K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™	NYSE:KVB	K V Pharma CL B
09/14/2010	9:29AM	Dow Jones News	K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval	NYSE:KVB	K V Pharma CL B
09/10/2010	8:53AM	Dow Jones News	K-V Pharma Soars On FDA Approval To Return Product To Market	NYSE:KVB	K V Pharma CL B
01/20/2010	2:41PM	Dow Jones News	UPDATE: Watson Pharma Benefits From Toprol Market Presence	NYSE:KVB	K V Pharma CL B
01/20/2010	1:11PM	Dow Jones News	Watson Pharma Continues To Benefit From Toprol Market Presence	NYSE:KVB	K V Pharma CL B
01/11/2010	8:18AM	PR Newswire (US)	KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)	NYSE:KVB
01/07/2010	3:10PM	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director	NYSE:KVB
12/15/2009	4:26PM	PR Newswire (US)	KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent	NYSE:KVB
12/02/2009	3:45PM	PR Newswire (US)	KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet	NYSE:KVB
11/13/2009	3:01PM	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	NYSE:KVB
10/07/2009	12:54PM	Dow Jones News	Large Generic Drug Cos Benefiting From Price Stability	NYSE:KVB	K-V Pharmaceutical Co. (Cl B)
09/21/2009	7:30AM	PR Newswire (US)	KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)	NYSE:KVB